A claim by Chinese scientists that a liquid made with honeysuckle and flowering plants could help fight the 2019 novel coronavirus has sparked frenzied buying of the traditional Chinese medicine, but doubts quickly emerged.
As the death toll from the coronavirus sweeping the nation continues to rise, shoppers have swamped pharmacies in search of Shuanghuanglian (雙黃連).
The rush came after Xinhua news agency on Friday last week reported that the Chinese Academy of Sciences had found the concoction “can inhibit” the virus.
Videos shared online showed long lines of people in masks lining up at night outside drug stores, purportedly in the hope of snapping up the product, despite official advice that people avoid public gatherings to prevent infection.
It quickly sold out both online and at brick-and-mortar stores, but responses to the remedy’s supposed efficacy have ranged from enthusiasm to skepticism on the Sina Weibo social media platform.
State media on Saturday sounded a more cautionary note, with broadcaster China Central Television airing an interview with Zhang Boli (張伯禮), one of the researchers leading outbreak containment efforts, who warned of the potential side effects of the medicine.
The People’s Daily newspaper said that experts advised against taking traditional remedies without professional guidance, but the claim came as Beijing looks to incorporate traditional Chinese medicine into its nationwide fight against the coronavirus.
Chinese Academy of Sciences researchers are also studying the potential use of a plant commonly known as Japanese knotweed to alleviate symptoms.
The Chinese National Health Commission on Tuesday last week said that traditional Chinese medicine practitioners were among nearly 6,000 reinforcement medical personnel being sent to Wuhan, the epicenter of the outbreak.
The strategy has reignited fierce and long-running debate about the efficacy of traditional Chinese medicine, which has a history going back 2,400 years and remains popular.
Chinese Medicine Academic Council of France member Marc Freard said that he believed traditional formulations could be used to treat people with symptoms ranging from fever to thick phlegm, but warned that many remedies on the market were of questionable quality and admitted that some medicine “lacks scientific standards of efficacy” because it relies on “individualized treatment.”
Traditional Chinese medicines were widely used in conjunction with Western methods during the 2002 and 2003 SARS epidemic, which killed 774 people worldwide.
However, a 2012 study in the Cochrane Database of Systematic Reviews found that combining Chinese and Western medicines “made no difference” in battling the disease.
The Chinese government has increasingly promoted traditional Chinese medicine abroad, often with nationalistic undertones.
Beijing issued its first white paper on traditional Chinese medicine in 2016, laying out plans to build centers and to dispatch practitioners to developing nations in Africa and Southeast Asia.
Chinese President Xi Jinping (習近平) has called it a “treasure of Chinese civilization” and said at a meeting in October last year that it should be given as much weight as other treatments.
China is “working hard to spread the message internationally about its traditional culture,” and medicine is a part of this, Freard said.
The WHO last year added traditional Chinese medicine to its “International Classification of Diseases” — a reference document for medical trends and global health statistics — after years of campaigning by Beijing, but the move was criticized by members of the scientific community, with the European Academies’ Science Advisory Council calling the decision “a major problem” because of the lack of evidence-based practice.
The WHO did not immediately respond to a request for comment.
Fang Shimin (方是民), a prominent Chinese writer known for his campaigns against academic fraud, said that he believes the Chinese government’s promotion of traditional medicine “panders to nationalism and has nothing to do with science.”
It is an enormous industry in China that was worth more than US$130 billion in 2016 — a third of the nation’s entire medical industry — Xinhua reported.
A coronavirus-free tropical island nestled in the northern Pacific might seem the perfect place to ride out a pandemic, but residents on Palau said that life right now is far from idyllic. The microstate of 18,000 people is among a dwindling number of places on Earth that still report zero cases of COVID-19 as figures mount daily elsewhere. The disparate group also includes Samoa, Turkmenistan, North Korea and bases on the frozen continent of Antarctica. A dot in the ocean hundreds of kilometers from its nearest neighbors, Palau is surrounded by the vast Pacific Ocean, which has acted as a buffer against the
Dutch scientists have found the coronavirus in a city’s wastewater before COVID-19 cases were reported, demonstrating a novel early warning system for the disease. SARS-CoV-2 — the virus that causes COVID-19 — is often excreted in an infected person’s stool. Although it is unlikely that sewage will become an important route of transmission, the pathogen’s increasing circulation in communities would increase the amount of it flowing into sewer systems, Gertjan Medema and colleagues at the KWR Water Research Institute in Nieuwegein said on Monday. They detected genetic material from the coronavirus at a wastewater treatment plant in Amersfoort on March 5, before
TRUE TOLL? Some Chinese are skeptical about official data, particularly given the overwhelmed medical system and initial attempts to cover up the outbreak The long lines and stacks of urns greeting family members of the dead at funeral homes in Wuhan, China, are spurring questions about the true scale of casualties at the epicenter of the COVID-19 outbreak, renewing pressure on a Chinese government struggling to control its containment narrative. The families of those who succumbed to the coronavirus in the city, where the disease first emerged, were allowed to pick up their cremated ashes at eight funeral homes last week. As they did, photographs circulated on Chinese social media of thousands of urns being ferried in. Outside one funeral home, trucks shipped in about 2,500
KEEN INTEREST: India is trying to procure medical gear from domestic producers and abroad, and China has emerged as a possible supplier as its factories reopen India is to buy ventilators and masks from China to help it deal with COVID-19, a government official said yesterday, even though some countries in Europe had complained about the quality of the equipment. India has recorded 1,251 cases of the coronavirus, with 32 deaths, but health experts said the country of 1.3 billion people could see a major surge in cases that could overwhelm its weak public health system. Indian Prime Minister Narendra Modi’s government said that it was trying to procure medical gear, including masks and body coveralls, both from domestic firms and from countries such as South Korea and